Disease Markers

Table of Contents

  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9786805
  • - Retraction

Retracted: Calycosin Inhibits the Malignant Behaviors of Lung Adenocarcinoma Cells by Regulating the circ_0001946/miR-21/GPD1L/HIF-1α Signaling Axis

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9785270
  • - Retraction

Retracted: Effects of Individualized Nursing Based on Zero-Defect Theory on Perioperative Patients Undergoing Laparoscopic Cholecystectomy

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9765649
  • - Retraction

Retracted: Identification of Candidate Therapeutic Target Genes and Profiling of Tumor-Infiltrating Immune Cells in Pancreatic Cancer via Integrated Transcriptomic Analysis

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9762735
  • - Retraction

Retracted: Effects of Fluid Shear Stress on Human Intervertebral Disc Nucleus Pulposus Cells Based on Label-Free Quantitative Proteomics

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9898020
  • - Retraction

Retracted: Overexpression of CAPG Is Associated with Poor Prognosis and Immunosuppressive Cell Infiltration in Ovarian Cancer

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9897082
  • - Retraction

Retracted: PTPN11 Gene Mutations and Its Association with the Risk of Congenital Heart Disease

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9893065
  • - Retraction

Retracted: Functional Analysis of Serum Long Noncoding RNAs in Patients with Atrial Fibrillation

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9876090
  • - Retraction

Retracted: Effect of HIV-1 Protease Inhibitor on IL-18 and IL-1β in Rats with Insulinoma

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9874732
  • - Retraction

Retracted: Clinical Characteristics of Diabetes Complicated by Bacterial Liver Abscess and Nondiabetes-Associated Liver Abscess

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9872910
  • - Retraction

Retracted: RUNX3-Regulated GALNT6 Promotes the Migration and Invasion of Hepatocellular Carcinoma Cells by Mediating O-Glycosylation of MUC1

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9871012
  • - Retraction

Retracted: CKS2 and S100A12: Two Novel Diagnostic Biomarkers for Rheumatoid Arthritis

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9867919
  • - Retraction

Retracted: HSPA5 Inhibitor Meliorate DSS-Induced Colitis through HSPA1A/CHIP

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9861026
  • - Retraction

Retracted: Effects of Atipamezole Preconditioning on Cognitive Function and Protein Expression in Related Brain Regions of Aged Rats after General Anesthesia

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9860627
  • - Retraction

Retracted: Effects of Infrared Combined with Methylcobalamin on the Vibratory Sensory Threshold and Nerve Conduction Velocity of the Lower Extremity in Patients with Diabetic Foot Treatment

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9857295
  • - Retraction

Retracted: Expression and Clinical Significance of HER2 Gene and DNMT1 in Non-Small-Cell Lung Cancer

Disease Markers
Disease Markers
 Journal metrics
See full report
Acceptance rate6%
Submission to final decision131 days
Acceptance to publication42 days
CiteScore3.700
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.